Effect of uric acid-lowering therapy on renal function in patients with chronic kidney disease 1-4:Meta-analysis

Objective To evaluate the efficacy of uric acid lowering therapy in delaying the progression of chronic kidney disease(CKD)and the incidence of adverse events.Methods The databases of PubMed, Embase, Web of Science, Cochrane Library, CNKI,WanFang and VIP were searched for screening, evaluating and e...

Full description

Saved in:
Bibliographic Details
Main Authors: Yin Ri-ping, Fan Zhen-liang, Yang Meng-fan, Song Li-qun
Format: Article
Language:zho
Published: Editorial Department of Journal of Clinical Nephrology 2021-01-01
Series:Linchuang shenzangbing zazhi
Subjects:
Online Access:http://www.lcszb.com/thesisDetails?columnId=57901756&Fpath=home&index=0
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850142935989878784
author Yin Ri-ping
Fan Zhen-liang
Yang Meng-fan
Song Li-qun
author_facet Yin Ri-ping
Fan Zhen-liang
Yang Meng-fan
Song Li-qun
author_sort Yin Ri-ping
collection DOAJ
description Objective To evaluate the efficacy of uric acid lowering therapy in delaying the progression of chronic kidney disease(CKD)and the incidence of adverse events.Methods The databases of PubMed, Embase, Web of Science, Cochrane Library, CNKI,WanFang and VIP were searched for screening, evaluating and extracting the relevant data from all eligible cohorts and randomized controlled studies on uric acid-lowering therapy for delayed progression of CKD.Finally random effect model or fixed effect model was utilized for summarizing the extracted data.Results Forty-six studies were eventually included(4,947 participants).Among 37 studies(3,802 participants),significant differences existed in serum uric acid changes[WMD-160.79,95%CI(-180.93,-140.65),P<0.001].Combined analysis of 31 studies(3,794 participants)showed significant differences in the changes of estimated glomerular filtration rate(eGFR)[WMD4.62,95%CI(3.33,5.91),P<0.001]and changes of serum creatinine(Scr)in 23 studies(2,026 participants)showed significant differences[WMD-30.13,95%CI(-37.56,-22.69),P<0.001].Although uric acid lowering therapy could lower the incidence of renal adverse events in patients with CKD 1-4,it offered no marked benefits in terms of reducing cardiovascular events and all-cause mortality.Conclusion Uric acid lowering therapy can improve glomerular filtration rate and delay the progression of CKD 1-4.However, this protective effect may be influenced by multiple factors.Whether or not uric acid lowering therapy is necessary in clinical practices require specific analysis.
format Article
id doaj-art-f0a0d01ba4844e1bb13ec6b83cd0d4da
institution OA Journals
issn 1671-2390
language zho
publishDate 2021-01-01
publisher Editorial Department of Journal of Clinical Nephrology
record_format Article
series Linchuang shenzangbing zazhi
spelling doaj-art-f0a0d01ba4844e1bb13ec6b83cd0d4da2025-08-20T02:28:54ZzhoEditorial Department of Journal of Clinical NephrologyLinchuang shenzangbing zazhi1671-23902021-01-0182683757901756Effect of uric acid-lowering therapy on renal function in patients with chronic kidney disease 1-4:Meta-analysisYin Ri-pingFan Zhen-liangYang Meng-fanSong Li-qunObjective To evaluate the efficacy of uric acid lowering therapy in delaying the progression of chronic kidney disease(CKD)and the incidence of adverse events.Methods The databases of PubMed, Embase, Web of Science, Cochrane Library, CNKI,WanFang and VIP were searched for screening, evaluating and extracting the relevant data from all eligible cohorts and randomized controlled studies on uric acid-lowering therapy for delayed progression of CKD.Finally random effect model or fixed effect model was utilized for summarizing the extracted data.Results Forty-six studies were eventually included(4,947 participants).Among 37 studies(3,802 participants),significant differences existed in serum uric acid changes[WMD-160.79,95%CI(-180.93,-140.65),P<0.001].Combined analysis of 31 studies(3,794 participants)showed significant differences in the changes of estimated glomerular filtration rate(eGFR)[WMD4.62,95%CI(3.33,5.91),P<0.001]and changes of serum creatinine(Scr)in 23 studies(2,026 participants)showed significant differences[WMD-30.13,95%CI(-37.56,-22.69),P<0.001].Although uric acid lowering therapy could lower the incidence of renal adverse events in patients with CKD 1-4,it offered no marked benefits in terms of reducing cardiovascular events and all-cause mortality.Conclusion Uric acid lowering therapy can improve glomerular filtration rate and delay the progression of CKD 1-4.However, this protective effect may be influenced by multiple factors.Whether or not uric acid lowering therapy is necessary in clinical practices require specific analysis.http://www.lcszb.com/thesisDetails?columnId=57901756&Fpath=home&index=0HyperuricemiaUric acidChronic kidney disease
spellingShingle Yin Ri-ping
Fan Zhen-liang
Yang Meng-fan
Song Li-qun
Effect of uric acid-lowering therapy on renal function in patients with chronic kidney disease 1-4:Meta-analysis
Linchuang shenzangbing zazhi
Hyperuricemia
Uric acid
Chronic kidney disease
title Effect of uric acid-lowering therapy on renal function in patients with chronic kidney disease 1-4:Meta-analysis
title_full Effect of uric acid-lowering therapy on renal function in patients with chronic kidney disease 1-4:Meta-analysis
title_fullStr Effect of uric acid-lowering therapy on renal function in patients with chronic kidney disease 1-4:Meta-analysis
title_full_unstemmed Effect of uric acid-lowering therapy on renal function in patients with chronic kidney disease 1-4:Meta-analysis
title_short Effect of uric acid-lowering therapy on renal function in patients with chronic kidney disease 1-4:Meta-analysis
title_sort effect of uric acid lowering therapy on renal function in patients with chronic kidney disease 1 4 meta analysis
topic Hyperuricemia
Uric acid
Chronic kidney disease
url http://www.lcszb.com/thesisDetails?columnId=57901756&Fpath=home&index=0
work_keys_str_mv AT yinriping effectofuricacidloweringtherapyonrenalfunctioninpatientswithchronickidneydisease14metaanalysis
AT fanzhenliang effectofuricacidloweringtherapyonrenalfunctioninpatientswithchronickidneydisease14metaanalysis
AT yangmengfan effectofuricacidloweringtherapyonrenalfunctioninpatientswithchronickidneydisease14metaanalysis
AT songliqun effectofuricacidloweringtherapyonrenalfunctioninpatientswithchronickidneydisease14metaanalysis